| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
268 |
224 |
$19K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
100 |
63 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,136 |
322 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
986 |
258 |
$4K |
| 80053 |
Comprehensive metabolic panel |
1,133 |
725 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,018 |
1,295 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
343 |
280 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
84 |
79 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
587 |
392 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
24 |
$242.79 |
| G0008 |
Administration of influenza virus vaccine |
41 |
25 |
$4.39 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$0.00 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
43 |
14 |
$0.00 |